comparemela.com

Latest Breaking News On - ஸ்டீபன் வில்லி - Page 3 : comparemela.com

Dicerna Pharmaceuticals Inc (DRNA) Q1 2021 Earnings Call Transcript

Operator Good afternoon, ladies and gentlemen, and welcome to the Dicerna Pharmaceuticals First Quarter 2021 Earnings Conference Call. As a reminder, this conference call is being recorded at the company s request. I will now turn the call over to your host, Will Grammig of Stern IR. Please go ahead. Lauren Stival Investor Relations Thank you, operator. Good afternoon, everyone, and thank you for joining us to review Dicerna s first quarter 2021 financial results and operational highlights. For anyone who hasn t yet had a chance to review our results we issued a press release after the close of trading today, which is available under the investors and media tab on our website at dicerna.com.

United statesRobyn karnauskasEd arceDoug paganHenry kranzlerDouglasw paganStephen willeyStephen willey stifelSheeram aradhyeMayank mamtaniSmith cowenRob williams goldman sachsDicerna galRob ciappenelliJim weissmanDouglasm fambrough

Seattle Genetics (SGEN) Q1 2021 Earnings Call Transcript

Seattle Genetics (SGEN) Q1 2021 Earnings Call Transcript Motley Fool Transcribing © The Motley Fool Logo of jester cap with thought bubble. Seattle Genetics (NASDAQ: SGEN) Good day and welcome to Seagen first-quarter 2021 financial results conference call. [Operator instructions] After today s presentation, there will be an opportunity to ask questions. Please note, this event is being recorded. I would now like to turn the conference over to Peggy Pinkston, senior vice president of investor relations. Please go ahead. Senior Vice President of Investor Relations Thank you, operator, and good afternoon, everyone. I d like to welcome all of you to Seagen s first-quarter 2021 financial results conference call. This afternoon, we issued a press release with our results. The press release and supporting slides are available on our website in the investor section, events and presentations page.

United kingdomUnited statesGreat britainCory kasimovAndy hsiehPeggy pinkstonSheldon chuan barclaysStephen willeyTisotumab vedotinGena wangSalveen richter goldman sachsConnor meehan morgan stanleyKennen mackayAndrew berensPadcev europeSalveen richter

MacroGenics (MGNX) Q1 2021 Earnings Call Transcript

MacroGenics (MGNX) Q1 2021 Earnings Call Transcript Motley Fool Transcribing © The Motley Fool Logo of jester cap with thought bubble. MacroGenics (NASDAQ: MGNX) Good afternoon, we will begin the MacroGenics 2021 first-quarter corporate progress and financial results conference call in just a moment. All participants are in listen-only mode at the moment, and we will conduct a question-and-answer session at the conclusion of the call. At this point, I will turn the call over to Jim Karrels, senior vice president, chief financial officer of MacroGenics. Jim Karrels Senior Vice President, Chief Financial Officer, and Treasurer Thank you, operator. Good afternoon and welcome to MacroGenics ss conference call to discuss our first-quarter 2021 financial and operational results. For anyone who has not had the chance to review these results, we issued a press release this afternoon, outlining today s announcements, which is available under the Investors tab

Hong kongJonathan miller evercoreEtzer darout cowenStephen willeyDavid lebowitzJonathan millerEtzer daroutJim karrelsJonathan changDavid lebowitz morgan stanleyPeter lawsonScott koenigYigal nochomovitzPeter lawson barclaysYigal nochomovitz citiBrad canino

Axion Ventures Inc : Axion Shareholders Vote with Overwhelming Majority to Elect Management Nominees as Directors in Annual Meeting

Axion Ventures Inc.: Axion Shareholders Vote with Overwhelming Majority to Elect Management Nominees as Directors in Annual Meeting Axion Ventures Inc. (TSXV: AXV) (OTC Pink: AXNVF) ( Axion or the Company ) is pleased to announce the results of voting at its Annual General and Special Meeting of Shareholders which was held earlier today in Vancouver, British Columbia (the Meeting ). All matters submitted to the shareholders for approval as set out in the Company s Notice of Meeting and Information Circular were approved at the Meeting. In addition, the management nominees named in the Company s Information Circular received over 129 million votes in their favour out of a total of 163 million shares voted. Accordingly, the directors of the Company are:

United kingdomBritish columbiaYasuyo yamazakiStephen willeyKunio hamadaMana prapakamolRobert adamsCompany informationCompany notice of meetingBritish columbia newsfile corpAxion ventures incRegulation services providerVenture exchangeAnnual generalSpecial meetingInformation circular

Innovega Receives Securities and Exchange Commission Qualification for $15 Million Offering

Innovega Receives Securities and Exchange Commission Qualification for $15 Million Offering Regulation A+ Offering is Officially Underway with Achievement of Threshold Investment News provided by Share this article Share this article BELLEVUE, Wash., April 13, 2021 /PRNewswire/ Innovega Inc. received SEC qualification for its $15 million Regulation A+ offering which set in motion the conversion of reservations to completed investments. The converted reservations reached the minimum threshold for the offering on April 11. Innovega Co-Founder and CEO Steve Willey commented, Investors exceeded our expectations and reserved approximately $1.5 million in shares by March 31. We were also pleased to receive our qualification of this Reg A+ offering by the Securities and Exchange Commission (SEC) on the same day. The SEC qualification allowed Innovega, through its partner SeedInvest, to transition these reservations to investments. He added, We secured our minimum target of $7

Steve willeyStephen willeyExchange commissionDefense advanced research projects agencyInnovega coNational science foundationInnovega incExchange commission under tierNational eye instituteNational institutesOffering statementFinal offering circularஸ்டீவ் வில்லிஸ்டீபன் வில்லிபரிமாற்றம் தரகுதேசிய அறிவியல் அடித்தளம்

vimarsana © 2020. All Rights Reserved.